Idexx Laboratories debt and dilution84

Borrowings, liquidity, share count and stock-based dilution.

Total debt

USD millions

$449.864M

Cash & equivalents

USD millions

$196.933M

Net debt

USD millions

$252.931M

Debt / equity

0.28×

Debt / assets

13.07%

Net debt / EBITDA

× · TTM

0.16×

Debt / FCF

× · TTM

0.36×

Interest coverage

× · TTM

38.6×

Current ratio

1.17×

Diluted shares

Million shares

79.31M shares

Basic shares

Million shares

78.95M shares

Share count growth

-1.81%

Share repurchases

USD millions

$346.804M

Quarterly data

Idexx Laboratories capital history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal period	Ended	Total debtUSD millions	Cash & equivalentsUSD millions	Net debtUSD millions	Debt / equity×	Debt / assets%	Net debt / EBITDA×	Debt / FCF×	Interest coverage×	Current ratio×	Diluted sharesMillion shares	Basic sharesMillion shares	Share count growth%	Share repurchasesUSD millions
FY 2026 Q2	Jun 30, 2026	449.86	196.93	252.93	0.28×	13.07%	0.16×	0.36×	38.6×	1.17×	79.31	78.95	-1.81%	346.8
FY 2026 Q1	Mar 31, 2026	449.85	200.53	249.32	0.29×	13.29%	0.16×	0.42×	36.12×	1.12×	80.16	79.65	-2.05%	351.04
FY 2025 Q4	Dec 31, 2025	449.84	180.07	269.77	0.28×	13.42%	0.18×	0.43×	35.01×	1.23×	80.48	79.9	-2.38%	237.77
FY 2025 Q3	Sep 30, 2025	524.82	208.17	316.66	0.34×	15.5%	0.22×	0.54×	35.17×	1.18×	80.68	80.1	-2.68%	240.2
FY 2025 Q2	Jun 30, 2025	524.81	164.59	360.21	0.36×	15.76%	0.26×	0.67×	36.72×	1.11×	80.99	80.41	-2.68%	338.11
FY 2025 Q1	Mar 31, 2025	620.73	163.97	456.76	0.43×	19.32%	0.36×	0.73×	37.01×	1.16×	81.92	81.32	-2.14%	400.89
FY 2024 Q4	Dec 31, 2024	617.57	288.27	329.31	0.39×	18.75%	0.26×	0.76×	36.16×	1.31×	82.56	81.85	-1.5%	245.99
FY 2024 Q3	Sep 30, 2024	623.9	308.64	315.26	0.39×	18.62%	0.25×	0.79×	33.72×	1.42×	83.06	82.3	-0.95%	220.76
FY 2024 Q2	Jun 30, 2024	694.86	401.59	293.27	0.44×	20.35%	0.24×	0.83×	31.94×	1.37×	83.39	82.63	-0.55%	215.52
FY 2024 Q1	Mar 31, 2024	695.78	397.43	298.34	0.44×	20.75%	0.24×	0.87×	30.68×	1.57×	83.96	83.1	0.13%	154.76
FY 2023 Q4	Dec 31, 2023	697.88	453.93	243.95	0.47×	21.41%	0.2×	0.9×	26.39×	1.57×	83.94	83.09	0.19%	36.85
FY 2023 Q3	Sep 30, 2023	768.8	331.7	437.11	0.59×	24.91%	0.37×	1.13×	23.51×	1.43×	83.99	83.1	-0.18%	35.07
FY 2023 Q2	Jun 30, 2023	771.84	132.84	639	0.71×	26.89%	0.55×	1.3×	21.73×	1.33×	83.98	83.09	-1%	0
FY 2023 Q1	Mar 31, 2023	771.35	111.37	659.98	0.92×	27.47%	0.63×	1.69×	20.24×	1.08×	83.96	82.99	-1.68%	0
FY 2022 Q4	Dec 31, 2022	769.37	112.55	656.82	1.26×	28.01%	0.65×	1.95×	22.55×	0.89×	83.83	82.93	-2.23%	74.02
FY 2022 Q3	Sep 30, 2022	760.81	99.18	661.64	1.6×	28.82%	0.67×	1.7×	25.79×	0.89×	84.11	83.25	-2.2%	172.63
FY 2022 Q2	Jun 30, 2022	768	114.36	653.63	1.68×	29.46%	0.68×	1.75×	28.49×	0.89×	84.86	83.92	-1.64%	306.77
FY 2022 Q1	Mar 31, 2022	773.38	204.62	568.76	1.21×	29.83%	0.55×	1.26×	31.92×	1.12×	85.56	84.41	-1.31%	266.3
FY 2021 Q4	Dec 31, 2021	850.2	144.45	705.75	1.23×	34.88%	0.68×	1.34×	31.27×	1.25×	86.16	84.83	-0.77%	244.76
FY 2021 Q3	Sep 30, 2021	853.02	145.2	707.81	1.13×	35.75%	0.69×	1.29×	30.44×	1.48×	86.51	85.12	-0.22%	181.23
FY 2021 Q2	Jun 30, 2021	905.06	232.13	672.93	1.21×	37.52%	0.7×	1.3×	27.74×	1.54×	86.65	85.33	0.22%	188.53
FY 2021 Q1	Mar 31, 2021	903.72	351.16	552.56	1.28×	38.83%	0.62×	1.36×	24.16×	1.77×	86.92	85.53	0.12%	132.26
FY 2020 Q4	Dec 31, 2020	908.48	383.93	524.55	1.44×	39.59%	0.66×	1.68×	20.97×	1.82×	86.98	85.49	-0.42%	0
FY 2020 Q3	Sep 30, 2020	903.3	175.59	727.71	2.05×	44.12%	1.01×	2.03×	19.12×	1.65×	86.69	85.31	-1.03%	0
FY 2020 Q2	Jun 30, 2020	—	105.29	—	—	—	—	—	18.72×	1.44×	86.4	85.13	-1.25%	0
FY 2020 Q1	Mar 31, 2020	—	81.4	—	—	—	—	—	18.58×	0.85×	86.71	85.43	-0.9%	182.82
FY 2019 Q4	Dec 31, 2019	698.91	90.33	608.58	3.93×	38.14%	0.95×	2.3×	17.8×	0.94×	87.27	85.84	-0.61%	140.69
FY 2019 Q3	Sep 30, 2019	—	104	—	—	—	—	—	17.15×	1.12×	87.67	86.2	-0.64%	85.98
FY 2019 Q2	Jun 30, 2019	—	110.85	—	—	—	—	—	15.78×	1.15×	87.62	86.22	-0.91%	20.69
FY 2019 Q1	Mar 31, 2019	—	116.62	—	—	—	—	—	15.11×	1.01×	87.55	86.2	-1.29%	54.3
FY 2018 Q4	Dec 31, 2018	601.78	123.79	477.98	—	39.14%	0.83×	2.12×	14.14×	0.85×	87.83	86.37	-1.2%	105.61
FY 2018 Q3	Sep 30, 2018	—	146.88	—	—	—	—	—	13.2×	0.93×	88.45	86.76	-0.89%	73.83
FY 2018 Q2	Jun 30, 2018	—	174.56	—	—	—	—	—	12.28×	0.96×	88.6	87	-1.14%	106.4
FY 2018 Q1	Mar 31, 2018	—	159.23	—	—	—	—	—	11.44×	0.96×	88.94	87.33	-0.89%	83.49
FY 2017 Q4	Dec 31, 2017	606.57	187.68	418.89	—	35.4%	0.84×	2.03×	11.1×	0.97×	89.07	87.43	-2.08%	53.87
FY 2017 Q3	Sep 30, 2017	—	169.02	—	—	—	—	—	11.32×	0.95×	89.26	87.54	-2.62%	57.9
FY 2017 Q2	Jun 30, 2017	—	165.98	—	—	—	—	—	11.63×	0.92×	89.88	88	-2.03%	106.89
FY 2017 Q1	Mar 31, 2017	—	160.41	—	—	—	—	—	11.4×	0.94×	89.99	88.12	-2.01%	63.91
FY 2016 Q4	Dec 31, 2016	593.66	154.9	438.76	—	38.78%	1.02×	2.2×	10.93×	0.9×	90.66	89.29	-1.71%	212.52
FY 2016 Q3	Sep 30, 2016	—	150.07	—	—	—	—	—	10.35×	1.09×	91.14	89.89	-2.23%	15.03
FY 2016 Q2	Jun 30, 2016	—	141.14	—	—	—	—	—	9.84×	1×	90.82	89.82	-3.81%	23.06
FY 2016 Q1	Mar 31, 2016	—	132.95	—	—	—	—	—	9.63×	0.92×	90.84	89.92	-4.62%	53.48
FY 2015 Q4	Dec 31, 2015	597.09	128.99	468.09	—	40.48%	1.27×	4.47×	10.26×	0.96×	91.83	90.84	-4.88%	92.92
FY 2015 Q3	Sep 30, 2015	—	141.15	—	—	—	—	—	10.03×	1.01×	92.9	91.94	-7.58%	88.96
FY 2015 Q2	Jun 30, 2015	—	163.15	—	—	—	—	—	11.53×	1.07×	94.31	93.38	-8.67%	86.45
FY 2015 Q1	Mar 31, 2015	—	182.16	—	—	—	—	—	13.87×	1.01×	95.52	94.28	-8.67%	133.65
FY 2014 Q4	Dec 31, 2014	350	322.54	27.46	2.98×	25.29%	0.09×	2×	16.87×	0.93×	96.93	95.5	-8.11%	149.19
FY 2014 Q3	Sep 30, 2014	—	292.74	—	—	—	—	—	24.01×	1.11×	100.8	99.49	-5.16%	272.34
FY 2014 Q2	Jun 30, 2014	—	305.05	—	—	—	—	—	30.74×	1.17×	103.59	102.25	-4.74%	126.35
FY 2014 Q1	Mar 31, 2014	—	286.2	—	—	—	—	—	37.63×	1.32×	104.68	103.23	-5.44%	70.28
FY 2013 Q4	Dec 31, 2013	151.39	279.06	-127.66	0.29×	12.3%	-0.4×	0.9×	49.53×	1.36×	105.56	103.93	-5.04%	84.85
FY 2013 Q3	Sep 30, 2013	—	264.81	—	—	—	—	—	62.05×	1.05×	106.48	104.9	-4.53%	76.58
FY 2013 Q2	Jun 30, 2013	—	251.01	—	—	—	—	—	71.14×	1.11×	108.77	107.34	-2.56%	142.56
FY 2013 Q1	Mar 31, 2013	—	228.36	—	—	—	—	—	75.46×	1.35×	110.98	109.18	-1.12%	63.78
FY 2012 Q4	Dec 31, 2012	2.5	223.99	-221.48	0×	0.23%	-0.7×	0.02×	68.23×	1.4×	111.63	109.44	-1.84%	41.12
FY 2012 Q3	Sep 30, 2012	—	221.44	—	—	—	—	—	62.04×	1.37×	112.18	109.88	-3.11%	36.15
FY 2012 Q2	Jun 30, 2012	—	201.81	—	—	—	—	—	59.58×	1.32×	112.42	110.16	-3.84%	27.38
FY 2012 Q1	Mar 31, 2012	—	185.49	—	—	—	—	—	60.59×	1.25×	112.88	110.42	-3.91%	27.63
FY 2011 Q4	Dec 31, 2011	3.42	183.9	-180.48	0.01×	0.33%	-0.63×	0.02×	66.6×	1.2×	113.92	111.5	-2.97%	89.49
FY 2011 Q3	Sep 30, 2011	—	181.5	—	—	—	—	—	74.46×	1.52×	116.01	113.4	-1.6%	67.6
FY 2011 Q2	Jun 30, 2011	—	159.4	—	—	—	—	—	78.53×	1.66×	117.45	114.55	-0.82%	58.48
FY 2011 Q1	Mar 31, 2011	—	153.46	—	—	—	—	—	75.23×	1.71×	118.18	114.91	—	39.94
FY 2010 Q4	Dec 31, 2010	—	156.92	—	—	—	—	—	84.42×	1.62×	118.33	114.92	—	25.93
FY 2010 Q3	Sep 30, 2010	—	133.51	—	—	—	—	—	—	1.59×	118.55	115.24	—	33.43
FY 2010 Q2	Jun 30, 2010	—	117.98	—	—	—	—	—	—	1.51×	119.29	115.49	—	26

Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.

Market prices: Yahoo Finance · IDXX, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Total debt: Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
Cash & equivalents: Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
Net debt: Total debt − cash and equivalents. Negative means net cash.
Debt / equity: Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
Debt / assets: Total debt / total assets × 100.
Net debt / EBITDA: Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
Debt / FCF: Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
Interest coverage: TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
Current ratio: Current assets / positive current liabilities.
Diluted shares: Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
Basic shares: Reported weighted average basic shares, normalized for subsequent recorded stock splits.
Share count growth: Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
Share repurchases: Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.

SEC company facts · CIK 874716